Search Results
Antisense Therapeutics Presentation - NWR Virtual Small Cap Investor Conference, Series 2
Invex Therapeutics Presentation - NWR Virtual Small Cap Investor Conference, Series 2
Microba Presentation – NWR Virtual Small Cap Investor Conference, Series 2
Antisense Therapeutics – Investor Webinar October 2020
Antisense Therapeutics (ASX:ANP): Mark Diamond, Managing Director
Antisense Therapeutics further develops therapeutic for Duchenne Muscular Dystrophy with ATL1102
Webinar: Antisense Therapeutics Phase II Trial Final Data Results (June 2020)
Antisense Therapeutics (ASX:ANP) and Neuren Pharmaceuticals (ASX:NEU) – Iain Wilkie, Analyst
Biotech & Healthcare Webinar - Antisense Therapeutics (ASX:ANP)
Antisense Therapeutics (ASX: ANP), Mark Diamond Managing Director and CEO
ShareCafe 'Hidden Gems' Webinar - Antisense Therapeutics ASX:ANP
Q&A with StockPal - Antisense Therapeutics Limited (ASX:ANP)
